Find your next paid study

Intalight, IncNCT07355491

~$10 – $1,050

Phase 4

iStent Infinite and iDose TR for Management of Moderate to Severe Primary Open Angle Glaucoma Are a Safe and Effective Alternative to Filtering Surgery for IOP Reduction in Patients With Medically Uncontrolled Glaucoma. (POAG)

The Investigators will investigate the efficacy of combining the standalone iStent infinite and iDose that are minimally invasive surgical and drug depot optio…

Open Angle GlaucomaPigmentary GlaucomaPseudoexfoliation Glaucoma

Jonathon MyersNCT07228221

~$10 – $7,500

Primary Open Angle Glaucoma (POAG)

Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Intraocular Pressure in Non-Caucasian Open Angle Glaucoma Patients

The goal of this clinical trial is to to evaluate how well Direct Selective Laser Trabeculoplasty (DSLT) lowers eye pressure in eyes of adult, non-Caucasian pa…

Select Eye CareNCT07147647

~$10 – $7,500

Phase 3

A Prospective Randomized Control Trial of Pilocarpine Use After Combined Cataract/Kahook Dual Blade Surgery

The goal of this study is to determine whether using pilocarpine provides added benefit to the success of combined cataract + Kahook Dual Blade (KDB) surgery.

Glaucoma

Montefiore Medical CenterNCT03933631

Data Gathering for A10900

The objective of this study is to gather Optical Coherence Tomography (OCT) data on normal and diseased eyes

Retinal DiseaseHealthyGlaucoma+1 more

GlaucomaGlaucoma, Open-AngleGlaucoma; Drugs+3 more

~$10 – $1,050

Optos, PLCNCT07149740

Phase 4

The Effect of Lumify™ (Brimonidine Tartrate Ophthalmic Solution 0.025%) on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients Using Brimonidine 0.2%, 0.15%, or 0.1%

Glaucoma represents a group of conditions that cause damage to the optic nerve and can lead to irreversible vision loss. Current treatments are aimed at loweri…

Tulane UniversityNCT04007276

Pseudoexfoliation Glaucoma

The Safety and Efficacy of Direct SLT in Pseudoexfoliation Glaucoma

Prospective, multi-center, single arm, interventional study evaluating DSLT in patients with pseudoexfoliative glaucoma.

Vance Thompson VisionNCT07401290

~$10 – $7,500

Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications

To evaluate glaucoma patients' response to treatment with Xiidra, an FDA-approved drug for ocular surface discomfort, which will be prescribed as standard of c…

GlaucomaOcular Surface Disease

University of California, Los AngelesNCT04354545

~$10 – $750

Glaucoma, SuspectOptic Nerve Hypoplasia and Abnormalities of the Central Nervous SystemCongenital Coloboma of the Optic Nerve+1 more

A More Engaging Visual Field Test to Increase Use and Reliability in Pediatrics

The majority of young children do not think that visual field (VF) testing of peripheral vision is similar to a game; therefore, it is not surprising that they…

Nova Southeastern UniversityNCT02157025

Increasing Eye Care Utilization in Black Americans At High Risk For Glaucoma Using A Community-Engaged and Faith-Based Intervention

The purpose of this research is to evaluate if intervention and education can change the behavior of someone's willingness to see an eye care provider to preve…

Glaucoma

University of MichiganNCT06124521

How Does First Line Treatment With DSLT Perform in Treatment-naïve Patients With Newly Diagnosed Primary Open Angle Glaucoma

DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.

Open Angle Glaucoma (OAG)

Barnet Dulaney Perkins Eye CentersNCT06933836

~$10 – $1,125

Phase 4

24-hour Effect Of Rocklatan Compared With Latanoprost In Open Angle Glaucoma And Ocular Hypertension Patients

The purpose of this study is to evaluate the effect on 24-hour IOP reduction of netarsudil-latanoprost fixed combination in one eye compared to latanoprost alo…

Open Angle GlaucomaOcular Hypertension